<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">27920038</PMID>
      <DateCompleted>
        <Year>2017</Year>
        <Month>11</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>02</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1943-0264</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>9</Volume>
            <Issue>4</Issue>
            <PubDate>
              <Year>2017</Year>
              <Month>Apr</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>Cold Spring Harbor perspectives in biology</Title>
          <ISOAbbreviation>Cold Spring Harb Perspect Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>TGF-β Family Signaling in the Control of Cell Proliferation and Survival.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">a022145</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1101/cshperspect.a022145</ELocationID>
        <Abstract>
          <AbstractText>The transforming growth factor β (TGF-β) family controls many fundamental aspects of cellular behavior. With advances in the molecular details of the TGF-β signaling cascade and its cross talk with other signaling pathways, we now have a more coherent understanding of the cytostatic program induced by TGF-β. However, the molecular mechanisms are still largely elusive for other cellular processes that are regulated by TGF-β and determine a cell's proliferation and survival, apoptosis, dormancy, autophagy, and senescence. The difficulty in defining TGF-β's roles partly stems from the context-dependent nature of TGF-β signaling. Here, we review our current understanding and recent progress on the biological effects of TGF-β at the cellular level, with the hope of providing a framework for understanding how cells respond to TGF-β signals in specific contexts, and why disruption of such mechanisms may result in different human diseases including cancer.</AbstractText>
          <CopyrightInformation>Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yun</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alexander</LastName>
            <ForeName>Peter B</ForeName>
            <Initials>PB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xiao-Fan</ForeName>
            <Initials>XF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R01 CA154586</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2017</Year>
          <Month>04</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Cold Spring Harb Perspect Biol</MedlineTA>
        <NlmUniqueID>101513680</NlmUniqueID>
        <ISSNLinking>1943-0264</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059447" MajorTopicYN="N">Cell Cycle Checkpoints</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="Y">Cell Proliferation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002470" MajorTopicYN="Y">Cell Survival</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2016</Year>
          <Month>12</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2017</Year>
          <Month>11</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2016</Year>
          <Month>12</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">27920038</ArticleId>
        <ArticleId IdType="pmc">PMC5378054</ArticleId>
        <ArticleId IdType="doi">10.1101/cshperspect.a022145</ArticleId>
        <ArticleId IdType="pii">cshperspect.a022145</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Accili D, Arden KC. 2004. 
FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell
117: 421–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15137936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, et al.
2013. 
A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol
15: 978–990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3732483</ArticleId>
            <ArticleId IdType="pubmed">23770676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aguirre-Ghiso JA. 2007. 
Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer
7: 834–846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2519109</ArticleId>
            <ArticleId IdType="pubmed">17957189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ, et al.
2009. 
Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways. Cell
139: 757–769.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2818353</ArticleId>
            <ArticleId IdType="pubmed">19914168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alexandrow MG, Moses HL. 1995. 
Transforming growth factor β and cell cycle regulation. Cancer Res
55: 1452–1457.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7882352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aragon E, Goerner N, Zaromytidou AI, Xi Q, Escobedo A, Massagué J, Macias MJ. 2011. 
A Smad action turnover switch operated by WW domain readers of a phosphoserine code. Genes Dev
25: 1275–1288.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3127429</ArticleId>
            <ArticleId IdType="pubmed">21685363</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Azar R, Alard A, Susini C, Bousquet C, Pyronnet S. 2009. 
4E-BP1 is a target of Smad4 essential for TGF β-mediated inhibition of cell proliferation. EMBO J
28: 3514–3522.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2782102</ArticleId>
            <ArticleId IdType="pubmed">19834456</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Battegay EJ, Raines EW, Seifert RA, Bowenpope DF, Ross R. 1990. 
TGF-β induces bimodal proliferation of connective-tissue cells via complex control of an autocrine PDGF loop. Cell
63: 515–524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2171777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhowmick NA, Ghiassi M, Aakre M, Brown K, Singh V, Moses HL. 2003. 
TGF-β-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest. Proc Natl Acad Sci
100: 15548–15553.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC307605</ArticleId>
            <ArticleId IdType="pubmed">14657354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M, Böttinger EP. 2000. 
A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev
14: 187–197.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC316349</ArticleId>
            <ArticleId IdType="pubmed">10652273</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blobe GC, Liu X, Fang SJ, How T, Lodish HF. 2001. 
A novel mechanism for regulating transforming growth factor β (TGF-β) signaling. Functional modulation of type III TGF-β receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem
276: 39608–39617.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11546783</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bragado P, Estrada Y, Parikh F, Krause S, Capobianco C, Farina HG, Schewe DM, Aguirre-Ghiso JA. 2013. 
TGF-β 2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38 α/β signalling. Nat Cell Biol
15: 1351–U1210.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4006312</ArticleId>
            <ArticleId IdType="pubmed">24161934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Orntoft TF, Andersen CL, Dobbelstein M. 2008. 
p53-responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res
68: 10094–10104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2836584</ArticleId>
            <ArticleId IdType="pubmed">19074875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buckley S, Shi W, Driscoll B, Ferrario A, Anderson K, Warburton D. 2004. 
BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells. Am J Physiol Lung Cell Mol Physiol
286: L81–86.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12959928</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campisi J. 2013. 
Aging, cellular senescence, and cancer. Annu Rev Physiol
75: 685–705.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4166529</ArticleId>
            <ArticleId IdType="pubmed">23140366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassar L, Nicholls C, Pinto AR, Li H, Liu JP. 2009. 
Bone morphogenetic protein-7 induces telomerase inhibition, telomere shortening, breast cancer cell senescence, and death via Smad3. FASEB J
23: 1880–1892.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19193721</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cerezo A, Kalthoff H, Schuermann M, Schafer B, Boukamp P. 2002. 
Dual regulation of telomerase activity through c-Myc-dependent inhibition and alternative splicing of hTERT. J Cell Sci
115: 1305–1312.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11884529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalaux E, Lopez-Rovira T, Rosa JL, Pons G, Boxer LM, Bartrons R, Ventura F. 1999. 
A zinc-finger transcription factor induced by TGF-β promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS Lett
457: 478–482.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10471833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. 1997. 
Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature
389: 85–89.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9288972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen CR, Kang Y, Massagué J. 2001. 
Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor β growth arrest program. Proc Natl Acad Sci
98: 992–999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC14697</ArticleId>
            <ArticleId IdType="pubmed">11158583</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen CR, Kang Y, Siegel PM, Massagué J. 2002. 
E2F4/5 and p107 as Smad cofactors linking the TGFβ receptor to c-myc repression. Cell
110: 19–32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12150994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen W, Kirkbride KC, How T, Nelson CD, Mo J, Frederick JP, Wang XF, Lefkowitz RJ, Blobe GC. 2003. 
β-arrestin 2 mediates endocytosis of type III TGF-β receptor and down-regulation of its signaling. Science
301: 1394–1397.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12958365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, et al.
2005. 
RUNX3 suppresses gastric epithelial cell growth by inducing p21WAF1/Cip1 expression in cooperation with transforming growth factor β-activated SMAD. Mol Cell Biol
25: 8097–8107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1234316</ArticleId>
            <ArticleId IdType="pubmed">16135801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cipriano R, Kan CE, Graham J, Danielpour D, Stampfer M, Jackson MW. 2011. 
TGF-β signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci
108: 8668–8673.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3102347</ArticleId>
            <ArticleId IdType="pubmed">21555587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coffey RJ Jr, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE, Moses HL. 1988. 
Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor β. Mol Cell Biol
8: 3088–3093.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC363535</ArticleId>
            <ArticleId IdType="pubmed">2463471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conery AR, Cao Y, Thompson EA, Townsend CM Jr, Ko TC, Luo K. 2004. 
Akt interacts directly with Smad3 to regulate the sensitivity to TGF-β induced apoptosis. Nat Cell Biol
6: 366–372.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15104092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Coppé JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. 2008. 
Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol
6: 2853–2868.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2592359</ArticleId>
            <ArticleId IdType="pubmed">19053174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. 1995. 
Transforming growth-factor-β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci
92: 5545–5549.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC41732</ArticleId>
            <ArticleId IdType="pubmed">7777546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>David CJ, Huang YH, Chen M, Su J, Zou YL, Bardeesy N, Iacobuzio-Donahue CA, Massagué J. 2016. 
TGF-β tumor suppression through a lethal EMT. Cell
164: 1015–1030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4801341</ArticleId>
            <ArticleId IdType="pubmed">26898331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2010. 
Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell
39: 373–384.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2921543</ArticleId>
            <ArticleId IdType="pubmed">20705240</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Debacq-Chainiaux F, Borlon C, Pascal T, Royer V, Eliaers F, Ninane N, Carrard G, Friguet B, de Longueville F, Boffe S, et al.
2005. 
Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-β1 signaling pathway. J Cell Sci
118: 743–758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15671065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deheuninck J, Luo KX. 2009. 
Ski and SnoN, potent negative regulators of TGF-β signaling. Cell Res
19: 47–57.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3103856</ArticleId>
            <ArticleId IdType="pubmed">19114989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Derynck R, Zhang YE. 2003. 
Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature
425: 577–584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14534577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ. 1995. 
Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice. Development
121: 1845–1854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7600998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ding Y, Kim JK, Il Kim S, Na HJ, Jun SY, Lee SJ, Choi ME. 2010. 
TGF-β 1 Protects against mesangial cell apoptosis via induction of autophagy. J Biol Chem
285: 37909–37919.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2988393</ArticleId>
            <ArticleId IdType="pubmed">20876581</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dooley S, ten Dijke P. 2012. 
TGF-β in progression of liver disease. Cell Tissue Res
347: 245–256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3250614</ArticleId>
            <ArticleId IdType="pubmed">22006249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drasin DJ, Robin TP, Ford HL. 2011. 
Breast cancer epithelial-to-mesenchymal transition: Examining the functional consequences of plasticity. Breast Cancer Res
13: 226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3326549</ArticleId>
            <ArticleId IdType="pubmed">22078097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dunker N, Schmitt K, Krieglstein K. 2002. 
TGF-β is required for programmed cell death in interdigital webs of the developing mouse limb. Mech Develop
113: 111–120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11960699</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dupont S, Zacchigna L, Adorno M, Soligo S, Volpin D, Piccolo S, Cordenonsi M. 2004. 
Convergence of p53 and TGF-β signaling networks. Cancer Lett
213: 129–138.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15327827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, Miyazono K. 2001. 
Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation
J Biol Chem
276: 12477–12480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11278251</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ehata S, Hanyu A, Hayashi M, Aburatani H, Kato Y, Fujime M, Saitoh M, Miyazawa K, Imamura T, Miyazono K. 2007. 
Transforming growth factor-β promotes survival of mammary carcinoma cells through induction of antiapoptotic transcription factor DEC1. Cancer Res
67: 9694–9703.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17942899</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eisenman RN. 2001. 
Deconstructing myc. Genes Dev
15: 2023–2030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11511533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elston R, Inman GJ. 2012. 
Crosstalk between p53 and TGF-β signalling. J Signal Transduct
2012: 294097.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3321553</ArticleId>
            <ArticleId IdType="pubmed">22545213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, et al.
1996. 
MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell
86: 543–552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8752209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng XH, Derynck R. 2005. 
Specificity and versatility in TGF-β signaling through Smads. Annu Rev Cell Dev Biol
21: 659–693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16212511</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng XH, Lin X, Derynck R. 2000. 
Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15Ink4B transcription in response to TGF-β. EMBO J
19: 5178–5193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC302105</ArticleId>
            <ArticleId IdType="pubmed">11013220</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frederick JP, Liberati NT, Waddell DS, Shi Y, Wang XF. 2004. 
Transforming growth factor β-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol
24: 2546–2559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC355825</ArticleId>
            <ArticleId IdType="pubmed">14993291</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Frippiat C, Chen QM, Zdanov S, Magalhaes JP, Remacle J, Toussaint O. 2001. 
Subcytotoxic H2O2 stress triggers a release of transforming growth factor-β 1, which induces biomarkers of cellular senescence of human diploid fibroblasts. J Biol Chem
276: 2531–2537.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11060295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, De Robertis EM. 2007. 
Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell
131: 980–993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2200633</ArticleId>
            <ArticleId IdType="pubmed">18045539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gal A, Sjoblom T, Fedorova L, Imreh S, Beug H, Moustakas A. 2008. 
Sustained TGFβ exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene
27: 1218–1230.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17724470</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao S, Alarcon C, Sapkota G, Rahman S, Chen PY, Goerner N, Macias MJ, Erdjument-Bromage H, Tempst P, Massagué J. 2009. 
Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-β signaling. Mol Cell
36: 457–468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2796330</ArticleId>
            <ArticleId IdType="pubmed">19917253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao H, Chakraborty G, Lee-Lim AP, Mo Q, Decker M, Vonica A, Shen R, Brogi E, Brivanlou AH, Giancotti FG. 2012. 
The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites. Cell
150: 764–779.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3711709</ArticleId>
            <ArticleId IdType="pubmed">22901808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massagué J. 2006. 
C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell
10: 203–214.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16959612</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P. 2002. 
Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J
21: 1743–1753.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC125949</ArticleId>
            <ArticleId IdType="pubmed">11927558</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, daCosta LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, et al.
1996. 
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science
271: 350–353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8553070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hannon GJ, Beach D. 1994. 
p15INK4B is a potential effector of TGF-β-induced cell-cycle arrest. Nature
371: 257–261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8078588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA Jr, Wrana JL, et al.
1997. 
The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell
89: 1165–1173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9215638</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hishikawa K, Oemar BS, Tanner FC, Nakaki T, Luscher TF, Fujii T. 1999. 
Connective tissue growth factor induces apoptosis in human breast cancer cell line MCF-7. J Biol Chem
274: 37461–37466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10601320</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hocevar BA, Smine A, Xu XX, Howe PH. 2001. 
The adaptor molecule Disabled-2 links the transforming growth factor β receptors to the Smad pathway. EMBO J
20: 2789–2801.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC125498</ArticleId>
            <ArticleId IdType="pubmed">11387212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hu MC, Rosenblum ND. 2005. 
Smad1, β-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development
132: 215–225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15576399</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iavarone A, Massagué J. 1997. 
Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15. Nature
387: 417–422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9163429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. 1997. 
Smad6 inhibits signalling by the TGF-β superfamily. Nature
389: 622–626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9335505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ito Y, Miyazono K. 2003. 
RUNX transcription factors as key targets of TGF-β superfamily signaling. Curr Opin Genet Dev
13: 43–47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12573434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. 2002. 
TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol
4: 51–58.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11740493</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jiang P, Mizushima N. 2014. 
Autophagy and human diseases. Cell Res
24: 69–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3879707</ArticleId>
            <ArticleId IdType="pubmed">24323045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaneda A, Fujita T, Anai M, Yamamoto S, Nagae G, Morikawa M, Tsuji S, Oshima M, Miyazono K, Aburatani H. 2011. 
Activation of Bmp2-Smad1 signal and its regulation by coordinated alteration of H3K27 trimethylation in Ras-induced senescence. PLoS Genet
7: e1002359.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3207904</ArticleId>
            <ArticleId IdType="pubmed">22072987</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kang Y, Chen CR, Massagué J. 2003. 
A self-enabling TGFβ response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell
11: 915–926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12718878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katakura Y, Nakata E, Miura T, Shirahata S. 1999. 
Transforming growth factor β triggers two independent-senescence programs in cancer cells. Biochem Biophys Res Commun
255: 110–115.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10082664</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katakura Y, Nakata E, Tabira Y, Miura T, Teruya K, Tsuchiya T, Shirahata S. 2003. 
Decreased tumorigenicity in vivo when transforming growth factor β treatment causes cancer cell senescence. Biosci Biotechnol Biochem
67: 815–821.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12784623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000. 
Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol Cell
6: 1365–1375.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11163210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiyono K, Suzuki HI, Matsuyama H, Morishita Y, Komuro A, Kano MR, Sugimoto K, Miyazono K. 2009. 
Autophagy is activated by TGF-β and potentiates TGF-β-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res
69: 8844–8852.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19903843</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kobayashi A, Okuda H, Xing F, Pandey PR, Watabe M, Hirota S, Pai SK, Liu W, Fukuda K, Chambers C, et al.
2011. 
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone. J Exp Med
208: 2641–2655.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3244043</ArticleId>
            <ArticleId IdType="pubmed">22124112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Koesters R, Kaissling B, LeHir M, Picard N, Theilig F, Gebhardt R, Glick AB, Haehnel B, Hosser H, Groene HJ, et al.
2010. 
Tubular overexpression of transforming growth factor-β 1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells. Am J Pathol
177: 632–643.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2913362</ArticleId>
            <ArticleId IdType="pubmed">20616344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kretzschmar M, Doody J, Massagué J. 1997. 
Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. Nature
389: 618–622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9335504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuilman T, Peeper DS. 2009. 
Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer
9: 81–94.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19132009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Labbé E, Letamendia A, Attisano L. 2000. 
Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways. Proc Natl Acad Sci
97: 8358–8363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC26952</ArticleId>
            <ArticleId IdType="pubmed">10890911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larisch S, Yi Y, Lotan R, Kerner H, Eimerl S, Tony Parks W, Gottfried Y, Birkey Reffey S, de Caestecker MP, Danielpour D, et al.
2000. 
A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif. Nat Cell Biol
2: 915–921.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11146656</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsson J, Goumans MJ, Sjostrand LJ, van Rooijen MA, Ward D, Leveen P, Xu X, ten Dijke P, Mummery CL, Karlsson S. 2001. 
Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J
20: 1663–1673.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC145465</ArticleId>
            <ArticleId IdType="pubmed">11285230</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lasorella A, Benezra R, Iavarone A. 2014. 
The ID proteins: Master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer
14: 77–91.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24442143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P. 2004. 
Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction. EMBO J
23: 4018–4028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC524335</ArticleId>
            <ArticleId IdType="pubmed">15385967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lebrin F, Deckers M, Bertolino P, ten Dijke P. 2005. 
TGF-β receptor function in the endothelium. Cardiovasc Res
65: 599–608.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15664386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H, Xu D, Toh BH, Liu JP. 2006a. 
TGF-β and cancer: Is Smad3 a repressor of hTERT gene?
Cell Res
16: 169–173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16474430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. 2006b. 
Transforming growth factor-β regulation of immune responses. Annu Rev Immunol
24: 99–146.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16551245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J, Hu M, Davis CM, Wang J, Brunicardi FC, et al.
2006. 
PPM1A functions as a Smad phosphatase to terminate TGFβ signaling. Cell
125: 915–928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6309366</ArticleId>
            <ArticleId IdType="pubmed">16751101</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin S, Yang J, Elkahloun AG, Bandyopadhyay A, Wang L, Cornell JE, Yeh IT, Agyin J, Tomlinson G, Sun LZ. 2012. 
Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells. Mol Biol Cell
23: 1569–1581.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3327327</ArticleId>
            <ArticleId IdType="pubmed">22357622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maes H, Rubio N, Garg AD, Agostinis P. 2013. 
Autophagy: Shaping the tumor microenvironment and therapeutic response. Trends Mol Med
19: 428–446.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23714574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J. 2000. 
How cells read TGF-β signals. Nat Rev Mol Cell Biol
1: 169–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11252892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Massagué J. 2012. 
TGFβ signalling in context. Nat Rev Mol Cell Biol
13: 616–630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4027049</ArticleId>
            <ArticleId IdType="pubmed">22992590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. 2004. 
Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature
430: 226–231.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15241418</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menthena A, Koehler CI, Sandhu JS, Yovchev MI, Hurston E, Shafritz DA, Oertel M. 2011. 
Activin A, p15INK4b signaling, and cell competition promote stem/progenitor cell repopulation of livers in aging rats. Gastroenterol
140: 1009–1020.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3087123</ArticleId>
            <ArticleId IdType="pubmed">21147108</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Minagawa S, Araya J, Numata T, Nojiri S, Hara H, Yumino Y, Kawaishi M, Odaka M, Morikawa T, Nishimura SL, et al.
2011. 
Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol
300: L391–401.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3284316</ArticleId>
            <ArticleId IdType="pubmed">21224216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Miyazono K, ten Dijke P, Heldin CH. 2000. 
TGF-β signaling by Smad proteins. Adv Immunol
75: 115–157.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10879283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mizushima N, Komatsu M. 2011. 
Autophagy: Renovation of cells and tissues. Cell
147: 728–741.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22078875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morgan DO. 1997. 
Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol
13: 261–291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9442875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muñoz-Espín D, Serrano M. 2014. 
Cellular senescence: From physiology to pathology. Nat Rev Mol Cell Biol
15: 482–496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24954210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Muñoz-Espín D, Canamero M, Maraver A, Gomez-Lopez G, Contreras J, Murillo-Cuesta S, Rodriguez-Baeza A, Varela-Nieto I, Ruberte J, Collado M, et al.
2013. 
Programmed cell senescence during mammalian embryonic development. Cell
155: 1104–1118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24238962</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murakami G, Watabe T, Takaoka K, Miyazono K, Imamura T. 2003. 
Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol Biol Cell
14: 2809–2817.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC165678</ArticleId>
            <ArticleId IdType="pubmed">12857866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray AW. 2004. 
Recycling the cell cycle: Cyclins revisited. Cell
116: 221–234.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14744433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin NE, Heldin CH, et al.
1997. 
Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature
389: 631–635.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9335507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H, Cho KW. 2000. 
Interaction between Wnt and TGF-β signalling pathways during formation of Spemann’s organizer. Nature
403: 781–785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10693808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, et al.
2000. 
Activin receptor-like kinase 1 modulates transforming growth factor-β 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci
97: 2626–2631.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC15979</ArticleId>
            <ArticleId IdType="pubmed">10716993</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohgushi M, Kuroki S, Fukamachi H, O’Reilly LA, Kuida K, Strasser A, Yonehara S. 2005. 
Transforming growth factor β-dependent sequential activation of Smad, Bim, and caspase-9 mediates physiological apoptosis in gastric epithelial cells. Mol Cell Biol
25: 10017–10028.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1280259</ArticleId>
            <ArticleId IdType="pubmed">16260615</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pardali K, Kurisaki A, Moren A, ten Dijke P, Kardassis D, Moustakas A. 2000. 
Role of Smad proteins and transcription factor Sp1 in p21Waf1/Cip1 regulation by transforming growth factor-β. J Biol Chem
275: 29244–29256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10878024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park SM, Kim S, Choi JS, Hur DY, Lee WJ, Lee MS, Choe J, Lee TH. 2005. 
TGF-β inhibits Fas-mediated apoptosis of a follicular dendritic cell line by down-regulating the expression of Fas and caspase-8: Counteracting role of TGF-β on TNF sensitization of Fas-mediated apoptosis. J Immunol
174: 6169–6175.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15879113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perk J, Iavarone A, Benezra R. 2005. 
Id family of helix-loop-helix proteins in cancer. Nat Rev Cancer
5: 603–614.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16034366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA. 2001. 
TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol
3: 708–714.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11483955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pierce DF Jr, Johnson MD, Matsui Y, Robinson SD, Gold LI, Purchio AF, Daniel CW, Hogan BL, Moses HL. 1993. 
Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-β 1. Genes Dev
7: 2308–2317.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8253379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Planas-Silva MD, Weinberg RA. 1997. 
The restriction point and control of cell proliferation. Curr Opin Cell Biol
9: 768–772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9425340</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massagué J. 1994. 
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell
78: 59–66.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8033212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramjaun AR, Tomlinson S, Eddaoudi A, Downward J. 2007. 
Upregulation of two BH3-only proteins, Bmf and Bim, during TGFβ-induced apoptosis. Oncogene
26: 970–981.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16909112</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rao S, Tortola L, Perlot T, Wirnsberger G, Novatchkova M, Nitsch R, Sykacek P, Frank L, Schramek D, Komnenovic V, et al.
2014. 
A dual role for autophagy in a murine model of lung cancer. Nat Commun
5: 3056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24445999</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ray D, Terao Y, Nimbalkar D, Chu LH, Donzelli M, Tsutsui T, Zou X, Ghosh AK, Varga J, Draetta GF, et al.
2005. 
Transforming growth factor β facilitates β-TrCP-mediated degradation of Cdc25A in a Smad3-dependent manner. Mol Cell Biol
25: 3338–3347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1069597</ArticleId>
            <ArticleId IdType="pubmed">15798217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Remy I, Montmarquette A, Michnick SW. 2004. 
PKB/Akt modulates TGF-β signalling through a direct interaction with Smad3. Nat Cell Biol
6: 358–365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15048128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reynisdottir I, Massagué J. 1997. 
The subcellular locations of p15Ink4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev
11: 492–503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9042862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reynisdottir I, Polyak K, Iavarone A, Massagué J. 1995. 
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev
9: 1831–1845.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7649471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rich JN, Zhang M, Datto MB, Bigner DD, Wang XF. 1999. 
Transforming growth factor-β-mediated p15INK4B induction and growth inhibition in astrocytes is SMAD3-dependent and a pathway prominently altered in human glioma cell lines. J Biol Chem
274: 35053–35058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10574984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB. 1985. 
Type β transforming growth factor: A bifunctional regulator of cellular growth. Proc Natl Acad Sci
82: 119–123.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC396983</ArticleId>
            <ArticleId IdType="pubmed">3871521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodier F, Campisi J. 2011. 
Four faces of cellular senescence. J Cell Biol
192: 547–556.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3044123</ArticleId>
            <ArticleId IdType="pubmed">21321098</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ruzinova MB, Benezra R. 2003. 
Id proteins in development, cell cycle and cancer. Trends Cell Biol
13: 410–418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12888293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salm SN, Burger PE, Coetzee S, Goto K, Moscatelli D, Wilson EL. 2005. 
TGF-β maintains dormancy of prostatic stem cells in the proximal region of ducts. J Cell Biol
170: 81–90.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2171389</ArticleId>
            <ArticleId IdType="pubmed">15983059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sapkota G, Knockaert M, Alarcon C, Montalvo E, Brivanlou AH, Massagué J. 2006. 
Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-β pathways. J Biol Chem
281: 40412–40419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17085434</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scandura JM, Boccuni P, Massagué J, Nimer SD. 2004. 
Transforming growth factor β-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci
101: 15231–15236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC524079</ArticleId>
            <ArticleId IdType="pubmed">15477587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schlapbach R, Spanaus KS, Malipiero U, Lens S, Tasinato A, Tschopp J, Fontana A. 2000. 
TGF-β induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia. Eur J Immunol
30: 3680–3688.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11169411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuster N, Krieglstein K. 2002. 
Mechanisms of TGF-β-mediated apoptosis. Cell Tissue Res
307: 1–14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11810309</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schuster N, Dunker N, Krieglstein K. 2002. 
Transforming growth factor-β induced cell death in the developing chick retina is mediated via activation of c-jun N-terminal kinase and downregulation of the anti-apoptotic protein Bcl-XL. Neurosci Lett
330: 239–242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12270637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Senturk S, Mumcuoglu M, Gursoy-Yuzugullu O, Cingoz B, Akcali KC, Ozturk M. 2010. 
Transforming growth factor-β induces senescence in hepatocellular carcinoma cells and inhibits tumor growth. Hepatology
52: 966–974.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20583212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seoane J, Pouponnot C, Staller P, Schader M, Eilers M, Massagué J. 2001. 
TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol
3: 400–408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11283614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seoane J, Le HV, Massagué J. 2002. 
Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature
419: 729–734.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12384701</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seoane J, Le HV, Shen L, Anderson SA, Massagué J. 2004. 
Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell
117: 211–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15084259</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi Y, Massagué J. 2003. 
Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell
113: 685–700.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12809600</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shin I, Bakin AV, Rodeck U, Brunet A, Arteaga CL. 2001. 
Transforming growth factor β enhances epithelial cell survival via Akt-dependent regulation of FKHRL1. Mol Biol Cell
12: 3328–3339.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC60258</ArticleId>
            <ArticleId IdType="pubmed">11694570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shintani T, Klionsky DJ. 2004. 
Autophagy in health and disease: A double-edged sword. Science
306: 990–995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1705980</ArticleId>
            <ArticleId IdType="pubmed">15528435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al.
1992. 
Targeted disruption of the mouse transforming growth factor-β 1 gene results in multifocal inflammatory disease. Nature
359: 693–699.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3889166</ArticleId>
            <ArticleId IdType="pubmed">1436033</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel PM, Massagué J. 2003. 
Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer
3: 807–820.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14557817</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Siegel PM, Shu W, Massagué J. 2003. 
Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-β-mediated epithelial cell growth suppression. J Biol Chem
278: 35444–35450.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12824180</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Song K, Wang H, Krebs TL, Danielpour D. 2006. 
Novel roles of Akt and mTOR in suppressing TGF-β/ALK5-mediated Smad3 activation. EMBO J
25: 58–69.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1356360</ArticleId>
            <ArticleId IdType="pubmed">16362038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staller P, Peukert K, Kiermaier A, Seoane J, Lukas J, Karsunky H, Moroy T, Bartek J, Massagué J, Hanel F, et al.
2001. 
Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol
3: 392–399.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11283613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storer M, Mas A, Robert-Moreno A, Pecoraro M, Ortells MC, Di Giacomo V, Yosef R, Pilpel N, Krizhanovsky V, Sharpe J, et al.
2013. 
Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell
155: 1119–1130.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24238961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, van Kooten C, Muller G. 2001. 
TGF-β 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int
59: 579–592.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11168939</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su D, Zhu S, Han X, Feng Y, Huang H, Ren G, Pan L, Zhang Y, Lu J, Huang B. 2009. 
BMP4-Smad signaling pathway mediates adriamycin-induced premature senescence in lung cancer cells. J Biol Chem
284: 12153–12164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2673284</ArticleId>
            <ArticleId IdType="pubmed">19269967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su D, Peng X, Zhu S, Huang Y, Dong Z, Zhang Y, Zhang J, Liang Q, Lu J, Huang B. 2011. 
Role of p38 MAPK pathway in BMP4-mediated Smad-dependent premature senescence in lung cancer cells. Biochem J
433: 333–343.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21050181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. 2009. 
Modulation of microRNA processing by p53. Nature
460: 529–533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19626115</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tachibana I, Imoto M, Adjei PN, Gores GJ, Subramaniam M, Spelsberg TC, Urrutia R. 1997. 
Overexpression of the TGFβ-regulated zinc finger encoding gene, TIEG, induces apoptosis in pancreatic epithelial cells. J Clin Invest
99: 2365–2374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC508075</ArticleId>
            <ArticleId IdType="pubmed">9153278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takehara K, LeRoy EC, Grotendorst GR. 1987. 
TGF-β inhibition of endothelial-cell proliferation: Alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression. Cell
49: 415–422.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3494524</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tremain R, Marko M, Kinnimulki V, Ueno H, Böttinger E, Glick A. 2000. 
Defects in TGF-β signaling overcome senescence of mouse keratinocytes expressing v-Ha-ras. Oncogene
19: 1698–1709.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10763827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. 1998. 
SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell
95: 779–791.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9865696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tucker RF, Shipley GD, Moses HL, Holley RW. 1984. 
Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science
226: 705–707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6093254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T, Takahashi T. 1996. 
Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res
56: 5583–5585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8971158</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ulloa L, Doody J, Massagué J. 1999. 
Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature
397: 710–713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10067896</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Untergasser G, Gander R, Rumpold H, Heinrich E, Plas E, Berger P. 2003. 
TGF-β cytokines increase senescence-associated β-galactosidase activity in human prostate basal cells by supporting differentiation processes, but not cellular senescence. Exp Gerontol
38: 1179–1188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14580871</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valderrama-Carvajal H, Cocolakis E, Lacerte A, Lee EH, Krystal G, Ali S, Lebrun JJ. 2002. 
Activin/TGF-β induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP. Nat Cell Biol
4: 963–969.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12447389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vijayachandra K, Lee J, Glick AB. 2003. 
Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res
63: 3447–3452.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12839923</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Walenda G, Abnaof K, Joussen S, Meurer S, Smeets H, Rath B, Hoffmann K, Frohlich H, Zenke M, Weiskirchen R, et al.
2013. 
TGF-β1 does not induce senescence of multipotent mesenchymal stromal cells and has similar effects in early and late passages. PLoS ONE
8: e77656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3798389</ArticleId>
            <ArticleId IdType="pubmed">24147049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wicks SJ, Lui S, Abdel-Wahab N, Mason RM, Chantry A. 2000. 
Inactivation of smad-transforming growth factor β signaling by Ca2+-calmodulin-dependent protein kinase II. Mol Cell Biol
20: 8103–8111.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC86420</ArticleId>
            <ArticleId IdType="pubmed">11027280</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilkes MC, Mitchell H, Penheiter SG, Dore JJ, Suzuki K, Edens M, Sharma DK, Pagano RE, Leof EB. 2005. 
Transforming growth factor-β activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21–activated kinase-2. Cancer Res
65: 10431–10440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16288034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yagi K, Furuhashi M, Aoki H, Goto D, Kuwano H, Sugamura K, Miyazono K, Kato M. 2002. 
c-myc is a downstream target of the Smad pathway. J Biol Chem
277: 854–861.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11689553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yakymovych I, Ten Dijke P, Heldin CH, Souchelnytskyi S. 2001. 
Regulation of Smad signaling by protein kinase C. FASEB J
15: 553–555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11259364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S, Taketo MM, Karlsson S, Iwama A, Nakauchi H. 2011. 
Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell
147: 1146–1158.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22118468</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang X, Khosravi-Far R, Chang HY, Baltimore D. 1997. 
Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell
89: 1067–1076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2989411</ArticleId>
            <ArticleId IdType="pubmed">9215629</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang H, Kyo S, Takatura M, Sun L. 2001. 
Autocrine transforming growth factor β suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells. Cell Growth Differ
12: 119–127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11243466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoo J, Ghiassi M, Jirmanova L, Balliet AG, Hoffman B, Fornace AJ Jr, Liebermann DA, Böttinger EP, Roberts AB. 2003. 
Transforming growth factor-β-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem
278: 43001–43007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12933797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoon YS, Lee JH, Hwang SC, Choi KS, Yoon G. 2005. 
TGFβ1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene
24: 1895–1903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15688038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, Ideguchi H, Yamamoto K, Matsuhashi S. 2006. 
Involvement of programmed cell death 4 in transforming growth factor-β1-induced apoptosis in human hepatocellular carcinoma. Oncogene
25: 6101–6112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16682950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu Q, Pearson-White S, Luo K. 2005. 
Requirement for the SnoN oncoprotein in transforming growth factor β-induced oncogenic transformation of fibroblast cells. Mol Cell Biol
25: 10731–10744.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1316959</ArticleId>
            <ArticleId IdType="pubmed">16314499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu D, Wu J, Spee C, Ryan SJ, Hinton DR. 2009. 
BMP4 mediates oxidative stress-induced retinal pigment epithelial cell senescence and is overexpressed in age-related macular degeneration. J Biol Chem
284: 9529–9539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2666605</ArticleId>
            <ArticleId IdType="pubmed">19158083</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
